High-Performance Strategic Medical Plans

This 2nd position paper?of our 2023 Medical Series proposes 5 recommendations and several tools to develop High-Performance Strategic Medical Plans.

In case you missed them, here-after are the links to access to our 2023:

A) Position papers:

1. MSLs Activities & Best Practices?– Benchmarking study
2. Smart Pharma?Collection 2016 – 2022
3. French Pharma?Attractiveness
4. Pharma Industry –?Truths & Untruths

B) Report:

1. “The French Pharma Market 2022 - 2027 - Strategic Implications for Pharma companies” – Excerpts of a 329-page report (Order form)

If you want to know more about our Consulting & Training services, contact us!

Best regards,